Biomaterials Market Size & Share, by Type of Materials - (Metallic, Ceramic, Polymer, Natural); Application - (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound healing, Neurological Disorders, Tissue Engineering, Ophthalmology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 1375
  • Published Date: Feb 06, 2023
  • Report Format: PDF, PPT

Companies Dominating the Biomaterials Landscape

    • Covestro AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • HMA Group Holdings, LLC
    • Victrex plc
    • Corbion N.V.
    • Mitsubishi Chemical Group Holdings
    • AB Specialty Silicones, LLC
    • CeramTec GmbH
    • Olympus Corporation
    • Gelita AG
    • Evonik Industries AG 

Browse Key Market Insights with Data Illustration:


In The News

  • Olympus Corporation declared the acquisition of FH ORTHO SAS, to build its portfolio on novel solutions to use in MIS procedures in ligament repair and foot, ankle, and trauma surgery.

  •  FDA NEWS designated the Bonalive biomaterials’ bone graft substitute as Breakthrough Device. The orthopedic granules of the substitute are made of bioactive glass used to fill bony voids and gaps to protect against microbial colonization during the bone healing process.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 1375
  • Published Date: Feb 06, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising disposable income and the growing prevalence of neurological disorders are the major factors driving the growth of the botulinum toxin market.

The market is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2023-2033.

High cost of botulinum toxin methods and the rise of COVID-19 are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Merz Pharma GmbH & Co. KgaA, USWM LLC, Revance Therapeutics, Inc., Ipsen Group, Medytox, Inc., Nestlé S.A., HUGEL, Inc., AbbVie Inc., Galderma Group, and Evolus, Inc. and Object Pharma, Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, gender, age group, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying